Forte Biosciences
(NASDAQ) FBRX
Forte Biosciences Financials at a Glance
Market Cap
$330.46M
Revenue (TTM)
$0.00
Net Income (TTM)
$51.74M
EPS (TTM)
$-4.44
P/E Ratio
-5.94
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$27.11
Volume
436,447
Open
$25.73
Price
$27.11
Volume
436,447
Open
$25.73
Previous Close
$27.01
Daily Range
$25.73 - $29.62
52-Week Range
$4.90 - $35.62
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$27.11
Volume
436,447
Open
$25.73
Previous Close
$27.01
Daily Range
$25.73 - $29.62
52-Week Range
$4.90 - $35.62
FBRX News
FBRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Forte Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
17
CEO
Paul A. Wagner, PhD, CFA
Website
www.fortebiorx.comHeadquarters
Dallas, TX 75247, US
FBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-111%
Return on Capital
-64%
Return on Assets
-53%
Earnings Yield
-16.84%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$330.46M
Shares Outstanding
12.53M
Volume
436.45K
Short Interest
0.00%
Avg. Volume
209.74K
Financials (TTM)
Gross Profit
$39.00K
Operating Income
$36.60M
EBITDA
$35.44M
Operating Cash Flow
$30.75M
Capital Expenditure
$37.00K
Free Cash Flow
$30.78M
Cash & ST Invst.
$58.37M
Total Debt
$0.00
Forte Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$17.00K
-70.0%
Gross Margin
0.00%
N/A
Market Cap
$330.46M
N/A
Market Cap/Employee
$23.60M
N/A
Employees
14
N/A
Net Income
$17.68M
-110.7%
EBITDA
$17.66M
-105.0%
Quarterly Fundamentals
Net Cash
$93.41M
+470.9%
Accounts Receivable
$527.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-53.29%
N/A
Return on Invested Capital
-63.54%
N/A
Free Cash Flow
$14.05M
-72.8%
Operating Cash Flow
$14.00M
-72.1%